In the Hadden Lab, we explore a multitude of cellular signaling pathways, investigating the ways in which their dysfunction contributes to the development of human cancer. Using a variety of medicinal chemistry, organic synthesis and molecular biology techniques, we apply our knowledge to develop and improve therapeutic agents that target these pathways. Our research on these projects provides us with extensive experience in multiple areas of early-stage drug discovery, including assay design and implementation, rational drug design, hit-to-lead optimization, and small molecule synthesis and evaluation.
$7.8 Million
in research funding
75+
peer reviewed publications
2
Submitted U.S. Patents
Explore Our Projects
Contact Us
| Phone: | 860-486-8446 |
| Email: | kyle.hadden@uconn.edu |
| Address: | 69 N Eagleville Rd Unit 3092 Storrs, CT 06269 Pharmacy and Biology Building Office - PBB 628 Labs - PBB 510, 512, & 516 |